EXOPULSE

Trademark usage description

extracellular vesicles, namely, exosomes for medical use; extracellular vesicles for clinical use; biological preparations comprising extracellular ve Read More

Classification Information

Class [005]
Extracellular vesicles, namely, exosomes for medical use; extracellular vesicles for clinical use; biological preparations comprising extracellular vesicles known as exosomes for therapeutic applications; living cells for medical purposes; pharmaceutical preparations and substances; dermatological preparations; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations, namely, a drug delivery system comprising genetically (engineered) or purified extracellular vesicles for therapeutic use; pharmaceutical preparations, namely, extracellular vesicles to deliver protein or RNA for genetic therapy; extracellular vesicles used as materials for pharmaceutical products; biological preparations for medical purposes; biological preparations comprising extracellular vesicles; biological preparations comprising a therapeutic target protein-loaded extracellular vesicles; biological preparations comprising extracellular vesicles for pharmaceutical purposes; biological reagents for medical use; medical preparations and articles; none of the aforesaid products being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software.

Classification kind code

Class [040]
Custom manufacturing of pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles (such as exosomes) for therapeutic applications; custom manufacture services, namely the provision of a manufacturing platform to create pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles (such as exosomes) for therapeutic applications; consultancy with regard to afore mentioned services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software.

Classification kind code

Class [042]
Contract research and contract development in the field of pharmaceutical preparations and substances, cosmetics, dermatological preparations, biological preparations comprising extracellular vesicles (such as exosomes) for therapeutic applications; biotechnological and medical research and development; extracellular vesicles research and development for therapies; culturing cells and tissues for scientific research purposes; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services; biological research; clinical research; providing medical and scientific research information in the field of filtration of exosomes from blood; preparation for others of regulatory documents on requirements for goods, processes or services in the field of pharmaceuticals; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; laboratory diagnostics; clinical trials; consultancy with regard to afore mentioned services; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software.

Classification kind code

Mark Details

Serial Number

2343941

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 257 on 15^th Aug 2024	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 14^th Aug 2024	Created
Submitted for opposition 31 on 14^th Aug 2024	Formalized
Submitted for opposition 228 on 13^th May 2024	International Registration
Submitted for opposition 30 on 13^th May 2024	Filed